Changes in gene expression with iron loading and chelation in cardiac myocytes and non-myocytic fibroblasts

Journal of Molecular and Cellular Cardiology

Volumn 32, Issue 2, 2000, Pages 233-246

  Parkes, Joel G ^a   Liu, Ying ^a   Sirna, Josephine B ^a   Templeton, Douglas M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Deferiprone; Deferoxamine; Extracellular matrix; Fibrosis; Glyceraldehyde 3 phosphate dehydrogenase; Iron response element; Transforming growth factor

Indexed keywords

BIGLYCAN; COLLAGEN TYPE 1; DEFEROXAMINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IRON; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; REGULATOR PROTEIN; TRANSFERRIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CHELATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; IRON RESPONSIVE ELEMENT; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

ANIMALIA; EUKARYOTA;

EID: 0033839672     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1999.1068     Document Type: Article

References (65)

1. Cardiac iron overload in thalassemic patients: An endomyocardial biopsy study
2. Myocardial involvement in idiopathic hemochromatosis. Morphologic and clinical improvement following venisection
3. Iron-chelating therapy and the treatment of thalassemia
4. Potentiation of iron accumulation in cardiac myocytes during the treatment of iron overload in gerbils with the hydroxypyridinone iron chelator CP94
5. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major
6. Cardiac failure and myocardial fibrosis in a patient with thalassemia major (TM) treated with long-term deferiprone
7. Study of non-muscle cells of the adult mammalian heart: A fine structural analysis and distribution
8. Collagen chain mRNAs in isolated heart cells from young and adult rats
9. Aconitase, a two-faced protein: Enzyme and iron regulatory factor
10. Regulating the fate of mRNA: The control of cellular iron metabolism
11. Structure and function of IREs, the noncoding mRNA sequences regulating synthesis of ferritin, transferrin receptor and (erythroid) 5-amino-levulinate synthase
12. Molecular control of vertebrate iron metabolism: mRNA-Based regulatory circuits operated by iron, nitric oxide, and oxidative stress
13. The 5'-untranslated region of human transferrin mRNA, which contains a putative iron-regulatory element, is bound by purified iron-regulatory protein in a sequence-specific manner
14. Identification of a conserved and funtional iron-responsive element in the 5'-untranslated region of mammalian mitochondrial aconitase
15. The human Nramp2 gene: Characterization of the gene structure, alternative splicing, promoter region and polymorphisms
16. Iron regulatory proteins 1 and 2
17. Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2
18. Liver gene expression during chronic dietary iron overload in rats
19. The effect of iron status on glyceraldehyde 3-phosphate dehydrogenase expression in rat liver
20. Chronic iron overload causes activation of rat lipocytes in vivo
21. Suppression of HL-60 cell proliferation by deferoxamine: Changes in c-myc expression
22. Iron chelators induce apoptosis in proliferating cells
23. Role of iron in NF-κB activation and cytokine gene expression by rat hepatic macrophages
24. Effects of iron loading on uptake, speciation and chelation of iron in cultured myocardial cells
25. Heparin inhibits mitogen-activated protein kinase-dependent and -independent c-fos induction in mesangial cells
26. Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5' untranslated region of ferritin heavy- and light-subunit mRNAs
27. A specific mRNA binding factor regulates the iron-dependent stability of cytoplasmic transferrin receptor mRNA
28. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate dehydrogenase multigenic family
29. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy
30. The murine transforming growth factor-β precursor
31. cDNA Sequence for rat dermatan sulfate proteoglycan-II (decorin)
32. Complete nucleotide sequence of mouse 18S rRNA gene: Comparison with other available homologs
33. Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1
34. Expression of active iron regulatory factor from a full-length human cDNA by in vitro transcription/translation
35. Immunodetection and quantiration of the two forms of transforming growth factor β (TGF-β1) and TGF-β2) secreted by cells in culture
36. A microassay to quantitate collagen synthesis by cells in culture
37. A simple, rapid, and sensitive DNA assay procedure
38. Iron in the heart: Etiology and clinical significance
39. Reciprocal control of RNA-binding and aconitase in the regulation of the iron-responsive element binding protein: Role of the iron-sulfur cluster
40. Cloning of the cDNA encoding an mRNA regulatory protein - The human iron-responsive element-binding protein
41. In vivo and in vitro modulation of the mRNA-binding activity of iron-regulatory factor. Tissue distribution and effects of ceil proliferation, iron levels and redox state
42. Control of cellular iron homeostasis by iron-responsive elements in vivo
43. Model structure of decorin and implications for collagen fibrillogenesis
44. Role of transforming growth factor β and decorin in controlling fibrosis
45. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor β
46. Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex
47. The family of the small leucine-rich proteoglycans: Key regulators of matrix assembly and cellular growth
48. Quantification of transforming growth factor-β in biological material using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct
49. Late cardiac complications of chronic, severe, refractory anemia with hemochromatosis
50. 3+ transport by iron-loaded cardiac myocytes
51. An essential role for free radicals and derived species in signal transduction
52. AFT1: A mediator of iron regulated transcriptional control in Saccharomyces Cerevisiae
53. Iron-regulated DNA binding by the AFT1 protein controls the iron regulon in yeast
54. Cardiac involvement in secondary haemochromatosis: A catheter biopsy study and analysis of myocardium
55. Regulation of protein kinase C (PKC) expression by iron: Effect of different iron compounds on PKC-β and PKC-α gene expression and role of the 5'-flanking region of the PKC-β gene in the respons to ferric transferrin
56. Role of transforming growth factor-β in maintenance of function of cultured neonatal cardiac myocytes: Autocrine action and reversal of damaging effects of interleukin-1
57. Norepinephrine and ANG II stimulate secretion of TGF-β by neonatal rat cardiac fibroblasts in vitro
58. Transforming factor β in tissue firosis
59. Metals, oxidative stress, and hepatic fibrobenesis
60. 1 expression in rat ventricular myocytes
61. The bifunctional iron-responsive element binding protein/cytosolic aconitase: The role of active-site residues in ligand binding and regulation
62. 1
63. Cobalt and desferrioxamine reveal crucial members of the oxygen sensing pathway in HepG2 cells
64. Hypoxic regulation of endothelial glyceraldehyde-3-phosphate dehydrogenase